Indeed, Ricceri et al. demonstrated that ERCC1-ACC haplotype was significantly decreased in 456 patients with bladder cancer in a case-control study, whereas ERCC1-GAT haplotype (T allele in rs11615) was significantly more present [49]. This evidence concerns the gene ERCC1 and urinary bladder carcinoma.